QS vs. CRBU

Last updated Apr 2, 2026

Compare and contrast key facts about QuantumScape Corporation (QS) and Caribou Biosciences, Inc. (CRBU).

Performance

QS vs. CRBU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in QuantumScape Corporation (QS) and Caribou Biosciences, Inc. (CRBU). The values are adjusted to include any dividend payments, if applicable.

QS vs. CRBU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
QS QuantumScape Corporation	-40.40%	100.77%	-25.32%	22.57%	-74.45%	-1.11%
CRBU Caribou Biosciences, Inc.	25.16%	0.00%	-72.25%	-8.76%	-58.38%	-7.54%

Fundamentals

Market Cap QS : $3.75B CRBU : $188.13M
EPS QS : -$0.75 CRBU : -$1.58
PB Ratio QS : 3.21 CRBU : 1.54
Total Revenue (TTM) QS : $0.00 CRBU : $11.16M
Gross Profit (TTM) QS : -$51.97M CRBU : $9.85M
EBITDA (TTM) QS : -$391.87M CRBU : -$130.70M

Returns By Period

In the year-to-date period, QS achieves a -40.40% return, which is significantly lower than CRBU's 25.16% return.

QS

• 1D: -2.66%
• 1M: -9.87%
• YTD: -40.40%
• 6M: -57.44%
• 1Y: 52.21%
• 3Y*: -8.78%
• 5Y*: -33.92%
• 10Y*: —

CRBU

• 1D: 4.74%
• 1M: 8.15%
• YTD: 25.16%
• 6M: -11.95%
• 1Y: 136.59%
• 3Y*: -27.90%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

QS vs. CRBU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QS

QS Risk / Return Rank: 61
QS Sharpe Ratio Rank: 59
QS Sortino Ratio Rank: 69
QS Omega Ratio Rank: 64
QS Calmar Ratio Rank: 58
QS Martin Ratio Rank: 55

CRBU

CRBU Risk / Return Rank: 79
CRBU Sharpe Ratio Rank: 84
CRBU Sortino Ratio Rank: 82
CRBU Omega Ratio Rank: 75
CRBU Calmar Ratio Rank: 79
CRBU Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QS vs. CRBU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for QuantumScape Corporation (QS) and Caribou Biosciences, Inc. (CRBU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	QS	CRBU	Difference
Sharpe ratio Return per unit of total volatility	0.51	1.53	-1.02
Sortino ratio Return per unit of downside risk	1.59	2.30	-0.71
Omega ratio Gain probability vs. loss probability	1.19	1.26	-0.07
Calmar ratio Return relative to maximum drawdown	0.73	2.31	-1.58
Martin ratio Return relative to average drawdown	1.41	4.40	-2.99
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

QS vs. CRBU - Sharpe Ratio Comparison

The current QS Sharpe Ratio is 0.51, which is lower than the CRBU Sharpe Ratio of 1.53. The chart below compares the historical Sharpe Ratios of QS and CRBU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	QS	CRBU	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.51	1.53	-1.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.39	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.07	-0.41	+0.34

Correlation

The correlation between QS and CRBU is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

QS vs. CRBU - Dividend Comparison

Neither QS nor CRBU has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

QS vs. CRBU - Drawdown Comparison

The maximum QS drawdown since its inception was -97.36%, roughly equal to the maximum CRBU drawdown of -97.58%. Use the drawdown chart below to compare losses from any high point for QS and CRBU.

Drawdown Indicators

	QS	CRBU	Difference
Max Drawdown Largest peak-to-trough decline	-97.36%	-97.58%	+0.22%
Max Drawdown (1Y) Largest decline over 1 year	-67.68%	-51.06%	-16.62%
Max Drawdown (5Y) Largest decline over 5 years	-92.97%	—	—
Current Drawdown Current decline from peak	-95.28%	-93.43%	-1.85%
Average Drawdown Average peak-to-trough decline	-85.27%	-78.77%	-6.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.04%	26.83%	+8.21%

Volatility

QS vs. CRBU - Volatility Comparison

The current volatility for QuantumScape Corporation (QS) is 17.38%, while Caribou Biosciences, Inc. (CRBU) has a volatility of 21.37%. This indicates that QS experiences smaller price fluctuations and is considered to be less risky than CRBU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QS	CRBU	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.38%	21.37%	-3.99%
Volatility (6M) Calculated over the trailing 6-month period	60.08%	54.67%	+5.41%
Volatility (1Y) Calculated over the trailing 1-year period	103.87%	90.21%	+13.66%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	86.28%	87.51%	-1.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	106.92%	87.51%	+19.41%

Financials